基本信息
views: 31
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
My work concentrates on the surgical infection and antimicrobial therapy. More specifically, I have been studied intraabdominal infection and surgical site infection (SSI) for surgical infections, and pharmacokinetics/pharmacodynamics (PK/PD), invasive fungal disease and multidrug-resistant organisms for antimicrobial therapy. I have been engaged in antimicrobial stewardship in university hospital, and published several articles concerning appropriate antimicrobial therapy. I also conducted Japanese nation-wide surveillance studies for antimicrobial susceptibility of the organisms isolated from SSIs and several randomized clinical trial for the strategy to prevent SSIs. Finally, I developed three clinical practice Japanese guidelines as a chair-person such as management of invasive candidiasis; antimicrobial therapeutic drug monitoring (TDM); and antimicrobial prophylaxis to prevent SSI.
Research Interests
Papers共 346 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapyno. 9 (2024): 853-859
Journal of Infection and Chemotherapy (2024)
Journal of Infection and Chemotherapy (2024)
OCULAR IMMUNOLOGY AND INFLAMMATIONpp.1-9, (2023)
Pharmaceuticsno. 2 (2023): 518-518
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapyno. 8 (2023): 778-782
Research Square (Research Square) (2023)
Load More
Author Statistics
#Papers: 325
#Citation: 4766
H-Index: 36
G-Index: 49
Sociability: 7
Diversity: 1
Activity: 3
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn